Raymond James Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$793K Buy
88,492
+76,815
+658% +$688K ﹤0.01% 3709
2025
Q1
$87.6K Buy
11,677
+1,007
+9% +$7.55K ﹤0.01% 4512
2024
Q4
$80.2K Buy
+10,670
New +$80.2K ﹤0.01% 4511